CR241220P200000
- 44.50
- 0.000.00%
Crane Newsroom
China Resources Double-Crane Subsidiaries Secure Drug Approvals
Crane To Go Ex-Dividend On November 29th, 2024 With 0.205 USD Dividend Per Share
Crane NXT, Co. (NYSE:CXT) Shares Could Be 33% Below Their Intrinsic Value Estimate
Double-Crane Pharmaceutical Gets Approval for China Clinical Trial of Weight Loss Drug
Mobile Crane Market to USD 30.46 Billion by 2032 Owing to Surge in Construction and Infrastructure Development | Research Report by SNS Insider
Crane Company (CR) Was Downgraded to a Hold Rating at Stifel Nicolaus
Yongmao Tower Crane Accident Case Adjourned to June 2025
Those Who Invested in China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Three Years Ago Are up 104%
Crane NXT Management to Meet With DA Davidson
Global Autonomous Crane Revenues Set to Soar Past US$6 Billion by 2030 as Ports Embrace Advanced Tech
Yongmao Holdings Updates on Hong Kong Crane Accident
These 4 Measures Indicate That Crane (NYSE:CR) Is Using Debt Reasonably Well
China Approves Double-Crane Pharma Unit's Supplementary Drug Application for Eye Drops
Stifel Downgrades Crane to Hold, Maintains Price Target to $176
Crane Analyst Ratings
Smiths Group (LSE:SMIN) Leverages John Crane and AI for Growth, Eyes Market Value Upside
Syndax Wins FDA Approval for Leukemia Drug Revumenib
Kiosk Manufacturer Association: Self Service November 2024
Estimating The Fair Value Of Crane Company (NYSE:CR)
XCMG Crane to Showcase Cutting-Edge Products at Bauma China 2024